JP2011530514A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530514A5
JP2011530514A5 JP2011522119A JP2011522119A JP2011530514A5 JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5 JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
nos
acid sequences
sequences shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522119A
Other languages
English (en)
Japanese (ja)
Other versions
JP5730200B2 (ja
JP2011530514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/052044 external-priority patent/WO2010017070A1/en
Publication of JP2011530514A publication Critical patent/JP2011530514A/ja
Publication of JP2011530514A5 publication Critical patent/JP2011530514A5/ja
Application granted granted Critical
Publication of JP5730200B2 publication Critical patent/JP5730200B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522119A 2008-08-06 2009-07-29 抗ヘプシジン−25選択的抗体およびその使用 Expired - Fee Related JP5730200B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8655708P 2008-08-06 2008-08-06
US61/086,557 2008-08-06
PCT/US2009/052044 WO2010017070A1 (en) 2008-08-06 2009-07-29 Anti-hepcidin-25 selective antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2011530514A JP2011530514A (ja) 2011-12-22
JP2011530514A5 true JP2011530514A5 (https=) 2013-06-06
JP5730200B2 JP5730200B2 (ja) 2015-06-03

Family

ID=41165490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522119A Expired - Fee Related JP5730200B2 (ja) 2008-08-06 2009-07-29 抗ヘプシジン−25選択的抗体およびその使用

Country Status (19)

Country Link
US (1) US8609817B2 (https=)
EP (1) EP2328931B1 (https=)
JP (1) JP5730200B2 (https=)
KR (1) KR101462307B1 (https=)
CN (1) CN102112489B (https=)
AU (1) AU2009279865B2 (https=)
BR (1) BRPI0916624A2 (https=)
CA (1) CA2733497C (https=)
DK (1) DK2328931T3 (https=)
EA (1) EA201170312A1 (https=)
ES (1) ES2432018T3 (https=)
IL (1) IL210643A (https=)
MX (1) MX2011001363A (https=)
NZ (1) NZ590863A (https=)
PL (1) PL2328931T3 (https=)
PT (1) PT2328931E (https=)
UA (1) UA103032C2 (https=)
WO (1) WO2010017070A1 (https=)
ZA (1) ZA201100261B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608683B1 (en) * 2003-04-01 2011-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions
PE20091261A1 (es) * 2007-11-02 2009-08-17 Lilly Co Eli Anticuerpos anti-hepcidina
NZ606584A (en) 2010-08-16 2014-10-31 Pieris Ag Binding proteins for hepcidin
AU2012350654C1 (en) 2011-12-12 2018-05-10 Pieris Ag Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US10316103B1 (en) 2012-03-30 2019-06-11 Biocare Medical, Llc Systems and methods for anti-Uroplakin III antibodies
US20140120560A1 (en) * 2012-10-26 2014-05-01 Claresa Levetan Generation of new pancreatic beta cells
US10429390B2 (en) 2012-12-18 2019-10-01 Biocare Medical, Llc Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
US9657098B2 (en) * 2013-03-15 2017-05-23 Intrinsic Lifesciences, Llc Anti-hepcidin antibodies and uses thereof
WO2015051320A2 (en) * 2013-10-03 2015-04-09 Biocare Medical, Llc Anti-sox10 antibody systems and methods
WO2016027469A1 (ja) * 2014-08-21 2016-02-25 国立大学法人旭川医科大学 ヘプシジンのスプライシングバリアント並びに該バリアントを指標とした癌の診断方法
AU2015321462B2 (en) * 2014-09-22 2020-04-30 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
EP3268027B1 (en) 2015-03-13 2022-11-02 Institut National de la Santé et de la Recherche Médicale (INSERM) Hepcidin antagonists for use in the treatment of inflammation
CA3038894A1 (en) * 2016-09-28 2018-04-05 Board Of Regents, The University Of Texas System Antibody and protein therapeutic formulations and uses thereof
EP3559039A1 (en) 2016-12-22 2019-10-30 Università Degli Studi Magna Graecia Catanzaro A monoclonal antibody targeting a unique sialoglycosilated cancer-associated epitope of cd43
WO2018234538A1 (en) 2017-06-23 2018-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Hepcidin antagonist or agonist for use in the treatment of dysregulation of mo and/or mn metabolism
CN109948371B (zh) * 2019-03-07 2021-06-25 深圳市智税链科技有限公司 为区块链节点发放身份证书的方法及相关装置
CN114761013A (zh) 2019-09-27 2022-07-15 迪斯克医药公司 治疗骨髓纤维化和相关病症的方法
US12508262B2 (en) 2020-04-30 2025-12-30 Keros Therapeutics, Inc. Methods of using ALK2 inhibitors
WO2021231798A1 (en) 2020-05-13 2021-11-18 Disc Medicine, Inc. Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
WO2022098812A1 (en) 2020-11-04 2022-05-12 Keros Therapeutics, Inc. Methods of treating iron overload
EP4279924A4 (en) * 2021-01-18 2024-06-26 FUJIFILM Corporation ADSORPTION INHIBITOR FOR HEPCIDIN, ADSORPTION INHIBITOR METHOD, REFERENCE STANDARD, REAGENT, KIT AND MEASUREMENT METHODS

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE478145T1 (de) 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
US6262247B1 (en) 1999-08-30 2001-07-17 Incyte Genomics, Inc. Polycyclic aromatic hydrocarbon induced molecules
JP4944360B2 (ja) 2001-05-25 2012-05-30 アンスティテュ ナシオナル ド ラ サント エ ド ラ ルシュルシェ メディカル(アンセルム) 鉄ホメオスタシスの障害を治療するための医薬品を製造するためのヘプシジンの使用
CN1173737C (zh) 2002-10-21 2004-11-03 钱忠明 Hepcidin(海魄喜定)在制药中的应用
US7411048B2 (en) 2002-11-19 2008-08-12 Drg International, Inc. Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
US8017737B2 (en) 2002-11-19 2011-09-13 Hasan Kulaksiz Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor
CA2506668C (en) 2002-11-19 2014-08-19 Drg International, Inc. Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
EP1644416A4 (en) 2003-06-30 2007-08-29 Centocor Inc ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
JP2007518062A (ja) 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
AU2003271174A1 (en) * 2003-10-10 2005-04-27 Chugai Seiyaku Kabushiki Kaisha Double specific antibodies substituting for functional protein
US7723063B2 (en) * 2004-04-28 2010-05-25 Intrinsic Lifesciences Methods for measuring levels of bioactive human hepcidin
AU2006223374B2 (en) * 2005-03-11 2011-07-21 Aspira Women’s Health Inc. Biomarkers for ovarian cancer and endometrial cancer: hepcidin
TW201307390A (zh) * 2007-02-02 2013-02-16 Amgen Inc 海帕西啶(hepcidin)、海帕西啶拮抗劑及使用方法
GR1006896B (el) * 2007-08-24 2010-07-20 Ελληνικο Ινστιτουτο Παστερ, Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
WO2009044284A1 (en) 2007-10-02 2009-04-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antibodies specific for human hepcidin
PE20091261A1 (es) * 2007-11-02 2009-08-17 Lilly Co Eli Anticuerpos anti-hepcidina
CA2722600C (en) 2008-05-01 2014-01-21 Amgen Inc. Anti-hepcidin antibodies and methods of use

Similar Documents

Publication Publication Date Title
JP2011530514A5 (https=)
CA2733497C (en) Anti-hepcidin-25 selective antibodies and uses thereof
KR101669918B1 (ko) 사람 체액 중의 시스타틴 c의 측정방법
RU2010117018A (ru) Антитела к gdf8 и их применения
RU2014146707A (ru) Антитела против тофацитиниба и их применение для лекарственного мониторинга
JP6129956B2 (ja) 抗c−Met抗体
JPWO2007114337A1 (ja) 免疫凝集反応試薬キット及び抗原の測定方法
CN120192412B (zh) 抗T3抗体mAb32或抗原结合片段、制备方法和应用
JP6873995B2 (ja) ヘプシジンの検出用キット
CN117624367B (zh) 抗人cd141蛋白的兔单克隆抗体及其应用
CN104142406B (zh) 一种稳定的肌钙蛋白i检测试剂盒
WO2023013764A1 (ja) 非アルコール性脂肪性肝炎における線維化進行度および/または前記肝疾患の活動性を推定する方法
WO2017132062A1 (en) Cgrp antibodies and uses thereof
CN120040588B (zh) 抗T3抗体mAb68或抗原结合片段、制备方法和应用
KR20210073785A (ko) 호산구 유래 신경독과 특이적으로 결합하는 단일클론항체 및 이의 용도
JP7207517B2 (ja) App669-711の測定方法、及び測定用キット
JP7715637B2 (ja) 免疫反応を利用したアナライトの測定方法及び測定試薬
RU2010149317A (ru) Способ количественного определения специфических иммуноглобулинов g к низкомолекулярным соединениям в сыворотке крови
CN102597772B (zh) 5.9kDa肽的免疫学测定方法
RU2023100156A (ru) Диагностические анализы и наборы для детекции фолатного рецептора 1
JP2005298395A (ja) 抗重金属モノクローナル抗体およびその使用方法
WO2014073653A1 (ja) 腎炎の病変部位の検査方法およびそのための試薬